ArticleGlobal health action2013
Cost of treatment for breast cancer in central Vietnam.
Article in Global health action, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pooled it
- Comprehensive Review of Breast Cancer Consequences for the Patients and Their Coping Strategies: A Systematic Review.Cancer control : journal of the Moffitt Cancer CenterPooled it
- Cancer Medication Consumptions in Vietnam Between 2019 and 2023: An Analysis from the National Database.ClinicoEconomics and outcomes research : CEOR · 2026Article
- Direct medical cost analysis of breast cancer treatment at Jimma University Medical Center: a provider perspective.Cost effectiveness and resource allocation : C/E · 2025Article
- Economic Burden of Breast Cancer on Patients and their Caregivers in a Regional Health Setting in Thailand: A Prevalence-Based Cost-of-Illness Study.Asian Pacific journal of cancer prevention : APJCP · 2025Article
- Cost of illness of breast cancer in low- and middle-income countries: a systematic review.Health economics review · 2024Review
- Willingness to Pay for a Quality-Adjusted Life Year among Gastrointestinal Cancer Patients at a Tertiary Hospital of Vietnam, 2022.Asian Pacific journal of cancer prevention : APJCP · 2024Article
- Costs of breast cancer treatment incurred by women in Vietnam.BMC public health · 2022Article
- Article
- The out-of-pocket cost of breast cancer care at a public tertiary care hospital in Nigeria: an exploratory analysis.The Pan African medical journal · 2022Article
- Financial toxicity due to breast cancer treatment in low- and middle-income countries: evidence from Vietnam.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.The oncologist · 2021Article
- A qualitative study on the needs of cancer caregivers in Vietnam.Global health action · 2021Article
- The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective.International journal of environmental research and public health · 2020Article
- Breast Cancer messaging in Vietnam: an online media content analysis.BMC public health · 2020Article
- Experiences of accessing and using breast cancer services in Vietnam: a descriptive qualitative study.BMJ open · 2020Article
- Determining Breast Cancer Treatment Costs Using the Top Down Cost Approach.European journal of breast health · 2019Article
- Cost of Operating Population-Based Cancer Registries: Results from 4 Sub-Saharan African Countries.Journal of registry management · 2019Article
- Strengthening breast cancer services in Vietnam: a mixed-methods study.Global health research and policy · 2019Article
- Financial Impact of Complex Cancer Surgery in India: A Study of Pancreatic Cancer.Journal of global oncology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundIn recent years, cases of breast cancer have been on the rise in Vietnam. To date, there has been no study on the financial burden of the disease. This study estimates the direct medical cost of a 5-year treatment course for women with primary breast cancer in central Vietnam.
methodsRetrospective patient-level data from medical records at the Hue Central Hospital between 2001 and 2006 were analyzed. Cost analysis was conducted from the health care payers' perspective. Various direct medical cost categories were computed for a 5-year treatment course for patients with breast cancer. Costs, in US dollars, discounted at a 3% rate, were converted to 2010 after adjusting for inflation. For each cost category, the mean, standard deviation, median, and cost range were estimated. Median regression was used to investigate the relationship between costs and the stage, age at diagnosis, and the health insurance coverage of the patients.
resultsThe total direct medical cost for a 5-year treatment course for breast cancer in central Vietnam was estimated at $975 per patient (range: $11.7-$3,955). The initial treatment cost, particularly the cost of chemotherapy, was found to account for the greatest proportion of total costs (64.9%). Among the patient characteristics studied, stage at diagnosis was significantly associated with total treatment costs. Patients at later stages of breast cancer did not differ significantly in their total costs from those at earlier stages however, but their survival time was much shorter. The absence of health insurance was the main factor limiting service uptake.
conclusionFrom the health care payers' perspective, the Government subsidization of public hospital charges lowered the direct medical costs of a 5-year treatment course for primary breast cancer in central Vietnam. However, the long treatment course was significantly influenced by out-of-pocket payments for patients without health insurance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.